Drugs Made In America Acquisition Corp.

Report date
3/31/2026
Quarter
2026 Q1
Filed
5/15/2026
Shares
650,000
Value ($000)
6,825
Weight
1.9%
2025 Q2 - 2026 Q1 (4 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).